В постели с бактериями. История, наука и секреты микроскопических существ, о которых не принято говорить - Парк Айна

Наконец, спасибо моим близким и всем, кто меня поддерживал: Джеймсу и Янг Пакам (James and Young Park), Тони Парку и Джейни Чэн (Tony Park and Janey Chan), Теду и Мэри Байерам (Ted and Mary Byers), Дональду и Ариоле Диксон (Donald and Ariola Dixon), Доре Эрнандез (Dora Hernandez), Арачели Гизар (Araceli Guizar), Чин Пи (Chih Pi), моим детям Нейту и Зайну, а больше всех – моему мужу Мэтту Диксону. Спасибо, что сидел с детьми, кормил меня и любил. Прости, что была такой ворчуньей последние три года.

Источники

ГЛАВА ПЕРВАЯ. УНИЧТОЖЕНИЕ АЛОЙ БУКВЫ «Г»

1. Wertheim J. O, Smith M. D, Smith D. M., Scheffler K, Kosakovsky Pond S. L. Evolutionary origins of human herpes simplex viruses 1 and 2. Mol Biol Evol. 2014 Sep 1;31(9):2356–64.

2. Hutfield D. C. History of herpes genitalis. Br J Vener Dis. 1966 Dec;42(4): 263–8.

3. Moholy-Nagy S. The Architecture of Paul Rudolph. New York: Praeger; 1970:233. http://prudolph.lib.umassd.edu/node/4561.

4. United States Food and Drug Administration. Drugs, devices, and the FDA: part 1: an overview of approval processes for drugs. Available at: https://www.fda.gov/Drugs/DevelopmentApprovalProcess/default.htm. Accessed February 18, 2018.

5. King D. H. History, pharmacokinetics, and pharmacology of acyclovir. J Am Acad Dermatol. 1988;18(1 Pt 2):176–9.

6. Cuatrecasas P. Drug discovery in jeopardy. J Clin Invest. 2006;116(11):2837–2842.

7. Leo J. The new scarlet letter. Time. 1982;120(5). Available at: http://content.time.com/time/subscriber/article/0,33009,1715020,00.html. Accessed January 7, 2018.

8. McInnis D. Herpes: Burroughs Wellcome sees its treatment as a way to cure profit ills. New York Times. June 19, 1983. Available at: https://www.nytimes.com/1983/06/19/business/herpes-burroughs-wellcome-sees-ts-treatment-as-a-way-to-cure-profit-ills.html. Accessed February 14, 2018.

9. McCaffrey K. Drugmakers again boost DTC spending, to $5.6 billion in 2016. MM&M. March 3, 2017. Available at: https://www.mmm-online.com/features/has-tc-in-the-oncology-space-kept-up-with-science/article/747441/. Accessed March 18, 2018.

10. Donohue J. A History of drug advertising: the evolving roles of consumers and consumer protection. Milbank Q. 2006;84(4):659–99.

11. Mogull S. A.. Chronology of direct-to-consumer advertising regulation in the United States. AMWA Journal. 2008;23(3):106–9.

12. Morris L. A., Mazis M. B., Brinberg D. Risk disclosures in televised prescription drug advertising to consumers. J Public Policy Mark. 1989;8:64–80.

13. Stevenson R. W. COMPANY NEWS; Glaxo offers $14 billion for Wellcome. New York Times. January 24, 1995. Available at: http://www.nytimes.com/1995/01/24/business/company-news-glaxo-offers-14-billion-for-wellcome.html. Accessed March 18, 2018.

14. Corey L, Reeves W. C., Chiang WT, Vontver L. A., Remington M, Winter C, Holmes K. K. Ineffectiveness of topical ether for the treatment of genital herpes simplex virus infection. N Engl J Med. 1978 Aug 3;299(5):237–9.

15. Fleming D. T., McQuillan G. M., Johnson R. E., Nahmias A. J., Aral S. O., Lee F. K., St Louis M. E. Herpes simplex virus Type 2 in the United States, 1976 to 1994. N Engl J Med. 1997 Oct 16;337(16):1105–11.

16. US Preventive Services Task Force, Bibbins-Domingo K, Grossman D. C., Curry S. J., Davidson K. W., Epling J. W. Jr, Garcia F. A., Kemper A. R., Krist A. H., Kurth A. E., Landefeld C. S., Mangione C. M., Phillips W. R., Phipps M. G., Pignone M. P., Silverstein M, Tseng C. W. Serologic screening for genital herpes infection: U.S. Preventive Services Task Force recommendation statement. JAMA. 2016 Dec 20;316(23):2525–30.

17. Agyemang E, Le Q. A., Warren T, Magaret A. S., Selke S, Johnston C, Jerome K. R., Wald A. Performanceof commercial enzyme-linked immunoassays for diagnosis of herpes simplex virus-1 and herpes simplex virus-2 infection in a clinical setting. Sex Transm Dis. 2017 Dec;44(12):763–7.

18. Kaufman A. The STD that keeps most contestants from competing on “The Bachelor.” New York Post. February 27, 2018. Available at: https://nypost.com/2018/02/27/the-std-that-keeps-most-contestants-from-competing-on-the-bachelor/. Accessed March 1, 2018.

19. Wald A. Hermeneutics of herpes: the American sexually transmitted diseases association distinguished career award lecture. Sex Transm Dis. 2017 Jan;44(1):1–5.

20. Mancuso R. Asking for a Friend: A True Story of Surviving Herpes and Receiving a Functional Cure from a Vaccine – One You Are Not Allowed to Get. Noisy Cricket; 2017.

21. Johnston C, Gottlieb S. L., Wald A. Status of vaccine research and development of vaccines for herpes simplex virus. Vaccine. 2016 Jun 3;34(26):2948–52.

22. Xu C. C., Dziegielewski P. T., McGaw W. T., Seikaly H. Sinonasal undifferentiated carcinoma (SNUC): the Alberta experience and literature review. J Otolaryngol Head Neck Surg. 2013 Jan 31;42:2.

23. Mancuso R. Patient zero: the life and work of Dr. Bill Halford. Available at: https://www.youtube.com/watch?v=NOjqjfL7pos&feature=youtu.be.

24. Rational Vaccines. Informed consent to participate in a phase I clinical trial of a therapeutic HSV-2 vaccine. Available at: https://kaiserhealthnews.files.wordpress.com/2017/10/consent-form-for-susan.pdf. Accessed June 25, 2018.

25. PR News Wire. First ever human trial of a live attenuated functioning therapeutic herpes vaccine. October 27, 2016. Available at: https://www.prnewswire.com/news-releases/first-ever-human-trial-of-a-live-ttenuated-functioning-therapeutic-herpes-vaccine-300345431.html. Accessed June 25, 2018.

26. Halford W. P. Genital herpes meets its match: a live HSV-2 ICP0 —virus vaccine that succeeds where subunit vaccines have failed. Available at: https://kaiserhealthnews.files.wordpress.com/2017/10/halford-perspectives-manuscript-dec-2016.pdf. Accessed June 25, 2018.

27. Taylor M. Offshore human testing of herpes vaccine stokes debate over U.S. safety rules. Kaiser Health News. August 28, 2017. Available at: https://khn.org/news/offshore-rush-for-herpes-vaccine-roils-debate-over-u-s-safety-rules/. Accessed June 25, 2018.

28. Taylor M. St. Kitts launches probe of herpes vaccine tests on U.S. patients. Kaiser Health News. August 31, 2017. Available at: https://khn.org/news/st-kitts-launches-probe-of-herpes-vaccine-tests-on-u-s-patients/. Accessed June 25, 2018.

29. Taylor M. Desperate quest for herpes cure launched ‘rogue’ trial. Kaiser Health News. October 19, 2017. Available at: https://khn.org/news/desperate-quest-for-herpes-cure-launched-rogue-trial/. Accessed June 25, 2018.

30. Taylor M. Years before heading offshore, herpes researcher experimented on people in U.S. Kaiser Health News. November 21, 2017. Available at: https://khn.org/news/years-before-heading-offshore-herpes-researcher-experimented-on-people-in-u-s/. Accessed June 25, 2018.

31. Taylor M. FDA launches criminal investigation into unauthorized herpes vaccine research. Kaiser Health News. April 18, 2018. Available at: https://khn.org/news/fda-launches-criminal-investigation-into-unauthorized-herpes-vaccine-research/. Accessed June 25, 2018.

32. Taylor M. Participants in rogue herpes vaccine research take legal action. Kaiser Health News. March 13, 2018. Available at: https://khn.org/news/participants-in-rogue-herpes-vaccine-research-take-legal-action/. Accessed June 25, 2018.

33. Oseso L, Magaret A. S, Jerome K. R, Fox J, Wald A. Attitudes and willingness to assume risk of experimental therapy to eradicate genital herpes simplex virus infection. Sex Transm Dis. 2016 Sep;43(9):566–71.